Generated 2026-03-19Phase 5Rating: BuyLegacy format
A smart water infrastructure compounder with a narrow but stable moat, strong cash conversion, and a software-led margin expansion story anchored by municipal metering and AMI adoption.
Generated 2026-03-23Phase 4Rating: Strong BuyLegacy format
A Latin American commerce and fintech ecosystem with a wide moat built on network effects, logistics, and payments infrastructure, framed as a high-conviction platform-scale compounder.
Generated 2026-02-01Phase 4Rating: BuyLegacy format
A platformising cybersecurity leader with a wide moat, strong recurring revenue, and significant M&A integration risk tied to CyberArk and Chronosphere.
Generated 2026-02-09Phase 4Rating: BuyLegacy format
A marketplace and super-app cash generator centred on operating leverage, Uber One retention, and the debate over AV disintermediation versus aggregation.
Generated 2026-03-20Phase 3Rating: Strong BuyLegacy format
A zero-trust security leader with strong free cash flow, high retention, and a valuation debate between operating quality and multiple compression.
Generated 2026-07-23Phase 5Rating: Monitoring stance; informational research only, not an investment recommendation
ServiceNow's July 22, 2026 results showed continued demand momentum: Q2 subscription revenue was USD 3.877 billion, constant-currency cRPO growth was 21.5%, and the number of customers above USD 5 million in ACV reached 658. The central public research question is whether those demand signals convert into sustained margin and cash-flow evidence in the next few quarters. ServiceNow Q2 2026 results
Generated 2026-07-13Phase 2Rating: Sell / Avoid
A quality-gated report on product momentum, technology moat, cash burn, debt maturities, and the evidence required to change a defensive stance.
Generated 2026-07-30undefinedRating: HOLD
Decision-first operating research with intrinsic scenarios; market-price comparisons are on demand only.
Generated 2026-07-17Phase 4Rating: Buy framework / hold at current valuation
ASML remains an exceptional semiconductor-equipment franchise, but the security offers little margin of safety at the dated USD 1,775.64 price. The accepted preliminary FCFF framework produces USD 479.68 Bear, USD 1,295.03 Base, and USD 1,858.81 Bull monitoring values, with a USD 1,232.14 probability-weighted result. The operating thesis remains supportive; the entry stance remains disciplined because the...
Generated 2026-07-17Phase 2Rating: Conditional buy / watch
Planet Labs is delivering strong growth and contracted visibility, but the dated USD 24.90 market price exceeds every locked valuation scenario. The revenue-to-FCFF framework produces USD 1.72 bear, USD 7.56 base, and USD 20.00 bull monitoring values, with a USD 8.00 probability-weighted result. The accepted stance remains conditional: keep the growth thesis on watch, but require a price below USD 20 or...
Generated 2026-07-17Phase 4Rating: SELL / AVOID
FTAI is executing well, but the security offers insufficient margin of safety at USD 203.70. Q1 2026 Aerospace Products revenue increased 104% to USD 743.8 million, adjusted EBITDA increased 70% to USD 222.6 million, and module production reached 270. Those results support the operating thesis. The valuation thesis is less attractive: the locked revenue-to-FCFF framework produces USD 32.97 bear, USD 187.53 base...
Generated 2026-07-18Phase 3Rating: HOLD / WATCH FOR A BETTER ENTRY
GitLab is a high-quality recurring software business with strong enterprise expansion, ample liquidity, no period-aligned debt, and positive free cash flow. The security is less compelling than the company: at USD 32.72, the shares trade above the USD 28.05 base-case FCFF value and USD 26.82 probability-weighted value. The public research stance is HOLD / WATCH, with no new-buy signal at the current price. The...
CBRS
Cerebras Systems Inc.
Generated 2026-07-19Phase 2Rating: WATCH / WAIT FOR OPERATING PROOF
Cerebras is an unusually fast-growing AI-infrastructure company with differentiated wafer-scale compute and substantial capacity investment. The public evidence supports demand and product relevance, but it does not yet establish durable per-share economics. Q1 FY2026 revenue was USD 193.4 million and GAAP operating margin was negative 7.8%; free cash flow was negative USD 119.6 million as capacity investment ran...
Generated 2026-07-23Phase 1Rating: WATCH — WAIT FOR OPERATING LEVERAGE
Carlsmed is showing strong product-level economics and commercial momentum, but it has not yet shown that growth can produce corporate operating leverage before cash consumption creates financing pressure. Q1 2026 revenue was USD 16.116 million, gross margin was 77.1%, operating margin was negative 57.6%, and free cash flow was negative USD 13.213 million. Carlsmed Q1 2026 earnings release Carlsmed Q1 2026 Form 10-Q
Generated 2026-07-31undefinedRating: HOLD
Decision-first operating research with intrinsic scenarios; market-price comparisons are on demand only.
Generated 2026-07-24Phase 5Rating: Watchlist; avoid a price-based conclusion until valuation inputs are public-primary and operating momentum is reconfirmed
Five9 entered 2026 with improving reported economics: Q1 revenue was USD 305.319 million, GAAP gross margin was 55.85%, GAAP operating margin was 6.06%, and free cash flow was USD 49.441 million. Management also reported 13% subscription-revenue growth and adjusted EBITDA of USD 74.5 million. These results support a company-level thesis of subscription-led growth with emerging operating leverage. Five9 Q1 2026...